|
VOLUME 30: NO. 8 AUGUST 2003
Editorials
Profits, Pressure, and Perception: Expensive
Research Collides with Medicine
 J. Hoey .........1661
Exclusivity versus the Hierarchy, or Fear
and Loathing of the Undefined
 R.E. Petty .........1663
Comment: Fibromyalgia Real or Imagined?
 D.A. Gordon .........1665
Pain is Real; Fibromyalgia Isn't
 G.E. Ehrlich .........1666
"Fibromyalgia" and the Medicalization of Misery
 N.M. Hadler .........1668
Stop Using the American College of Rheumatology Criteria in the Clinic
 F. Wolfe .........1671
Articles
Search for Correlation of CD8 T Cell Response to Epstein-Barr Virus with Clinical Status in RA: A 15 Month Followup Pilot Study
 J-M. Berthelot, X. Saulquin, M. Coste-Burel, et al .........1673
Preferential Induction of Prodestructive MMP-1 and Proinflammatory IL-6 and PGE2 in RA Synovial Fibroblasts via TNF Receptor 55
 S. Alsalameh, R.J. Amin, E. Kunisch, H.E. Jasin,
R.W. Kinne .........1680
The Predictive Value of Anti-Cyclic Citrullinated
Peptide Antibodies in Early Arthritis
 L.M.A. Jansen, D. van Schaardenburg,
I.E. van der Horst-Bruinsma, R.J. van de Stadt,
M.H.M.T. de Koning, B.A.C. Dijkmans .........1691
Recombinant Human Mab Specific for Citrulline-Containing Peptides from Phage Display Libraries Derived from Patients with RA
 J.M.H. Raats, E.M. Wijnen, G.J.M. Pruijn,
F.H.J. van den Hoogen, W.J. van Venrooij .........1696
Differential Expression of Leukotriene B4 Receptor Subtypes (BLT1 and BLT2) in Human Synovial Tissues and SF Leukocytes of Patients with RA
 A. Hashimoto, H. Endo, I. Hayashi, et al .........1712
Intraarticular Release and Accumulation of
Defensins and Bactericidal/Permeability-Increasing Protein in Patients with RA
 M.I. Bokarewa, T. Jin, A. Tarkowski .........1719
Toward a Definition and Method of Assessment of Treatment Failure and Treatment Effectiveness:
The Case of Leflunomide versus Methotrexate
 F. Wolfe, K. Michaud, B. Stephenson, J. Doyle .........1725
Description of Stable Pain in RA: A 6 Year Study
 P.A. Roche, A.C. Klestov, H.M. Heim .........1733
Reading and Interpreting Economic Evaluations
in RA: An Assessment of Selected Instruments for Critical Appraisal
 M.H. Weisman, A.D. Gano Jr, S.E. Gabriel, et al .........1739
Evidence for Immunostimulatory Effects of IM Gold in Patients with RA: Correlation with Skin Reactions
 S. Ernestam, J. Lampa, S. Rogberg, J. Rönnelid,
L. Klareskog, I. Hafström .........1748
Adherence to Ophthalmologic Monitoring for Antimalarial Toxicity in a Lupus Cohort
 S. Bernatsky, C. Pineau, L. Joseph, A. Clarke .........1756
Information on Diagnosis and Management of SLE Derived from the Routine Measurement of 8 Nuclear Autoantibodies
 G.P. Ignat, A-C. Rat, J.J. Sychra,
J. Vo, J. Varga, M. Teodorescu .........1761
Chemokine Receptor CCR2/CCR5 Polymorphism in Spanish Patients with SLE
 F. Aguilar, A. Núñez-Roldán, B. Torres, et al .........1770
IFN Plus Ribavirin in Patients with HCV Positive
Mixed Cryoglobulinemia Resistant to IFN
 C. Mazzaro, F. Zorat, C. Comar, et al .........1775
Frequency and Analysis of Factors Closely
Associated with the Development of Depressive Symptoms in Patients with Scleroderma
 E. Matsuura, A. Ohta, F. Kanegae, et al .........1782
A Systematic Review of the Outcomes of Digital Sympathectomy for Treatment of Chronic
Digital Ischemia
 S.V. Kotsis, K.C. Chung .........1788
Role of Immunosuppressive Therapy on Clinical, Immunological, and Angiographic Outcome in Active Takayasu's Arteritis
 A.K. Valsakumar, U. Chirammal Valappil, V. Jorapur,
N. Garg, S. Nityanand, N. Sinha .........1793
Expression of Granzyme B in Human Articular Chondrocytes
 K. Horiuchi, S. Saito, R. Sasaki, T. Tomatsu,
Y. Toyama .........1799
In Situ Immunophenotype of the Inflammatory
Infiltrate in Eosinophilic Fasciitis
 C. Toquet, M.A. Hamidou, K. Renaudin, et al .........1811
AS in Shantou, China: 15 Years' Clinical
Experience
 Q.Y. Zeng .........1816
The Risk of Contralateral Total Knee Arthroplasty
After Knee Replacement for OA
 M. McMahon, J.A. Block .........1822
Avocado/Soybean Unsaponifiables Increase
Aggrecan Synthesis and Reduce Catabolic and Proinflammatory Mediator Production by Human Osteoarthritic Chondrocytes
 Y.E. Henrotin, C. Sanchez, M.A. Deberg, et al .........1825
FM in an Amish Community: A Controlled
Study to Determine Disease and
Symptom Prevalence
 K.P. White, J. Thompson .........1835
Oral Symptoms Associated with FM
 N.L. Rhodus, J. Fricton, P. Carlson, R. Messner .........1841
Patient and Provider Factors Related to Comprehensive Arthritis Care in a Community
Setting in Ontario, Canada
 R.H. Glazier, E.M. Badley, J.G. Wright, et al .........1846
The Dunlop-Dottridge Lecture: Medical Publication Ethics
 D.A. Gordon .........1851
Pediatric Rheumatology
Classification of JIA: Should Family History Be Included in the Criteria?
 P. Manners, J. Lesslie, D. Speldewinde, D. Tunbridge .........1857
Case Reports
Etanercept Ameliorates Sarcoidosis Arthritis and
Skin Disease
 D. Khanna, M.R. Liebling, J.S. Louie .........1864
Intraarticular Tophi in a Joint Without a
Previous Gouty Attack
 K-H. Yu .........1868
Images in Rheumatology
IV Cyclophosphamide and High Dose Corticosteroids Improve MRI Lesions in Demyelinating Syndrome in SLE
 F.K. Leung, P.R. Fortin .........1871
Canadian Rheumatology Association Meeting
Mont Tremblant, Canada
February 26 - March 1, 2003
Introduction .........1874
Podium Presentations .........1875
Posters .........1876
Correspondence
The Approaching Crisis in Rheumatologic Care
A.J. Morris .........1890
Reply J. Lewtas .........1890
MTX, HCQ, and Intramuscular Gold in RA
S. Wassenberg, R. Rau .........1891
Reply D. Albert, F. Wolfe, J. Fries .........1891
Letter
MRI Criteria to Differentiate Inclusion Body Myositis from Polymyositis G.J.D. Hengstman .........1892
Notices

|